Rita Leporati

Medical Oncologist | Research Fellow @UNIMORE_univ | trained @IstTumori | #lungcancer

[Stephen V Liu, MD @StephenVLiu]

#CIOT26 Always a privilege to spend time with lung cancer faculty from around the world @NicolaNormanno @MartinReck2 @Ritalepp @APassaroMD @bensolomon1 @alexdrilon @EnriquetaFelip

[Lung Cancer Europe @LungCancerEu]

‼️ Landmark #lungcancer research published today in Cell

Scientists at the Francis Crick Institute and UCL have discovered a 14-protein blood signature that predicts lung cancer more than 5 years before diagnosis, works in never-smokers, and could identify who benefits from prevention treatment.

People with high levels of these proteins were the ones who actually benefited from a drug to damp that inflammation down, cutting their lung cancer risk nearly in half.

This could finally give us something lung cancer has never had: a way to prevent it in the people most at risk.

https://t.co/SaZwBHnxvZ

#LCSM

[Emma Zattarin @emmazattarin]

A reflection on oncology, literature, an the ways books can accompany patients and doctors through illness and hospital life. 📚📖 https://t.co/WtC2VKLPyJ

[EORTC @EORTC]

👏Yesterday marked the end of the EORTC ECI Programme for Early Career Investigators: 9 sessions, 40 ECIs!

EORTC fosters young doctors in clinical & translational cancer research.

Interested in becoming an ECI?

🔗 Learn more on our website: https://t.co/DplKeOgQcm

[JTO & JTO CRR @JTOonline]

Congrats to all participants of the @IASLC Reviewer Workshop! 🎉 We hope the skills gained will serve you throughout your career. Special thanks to our faculty, IASLC, JTO & JTO CRR for supporting reviewer excellence. #IASLC #PeerReview

[Lodovica Zullo @LodovicaZullo]

Italian National Team at #WCLC2025 @AriMarinel @RobertoFerrara_ @Max_Cani @Gmazzaschi90 @pecci_federica1 @doctordegio @CarloGenova5 and many others 🇮🇹🍕

[Rita Leporati @Ritalepp]

@emmazattarin @angela_toss Super ❤️👏🏻

[Jose Carlos Benitez @JcbenitezMD]

What happens when Young Lung Cancer minds from @EORTC meet in Paris?
Brains, baguettes & bevs at brasserie Circus! 🧠 🥖 🍷 🍻
Science, collaboration and connections with friends beyond the sessions. #EORTClung #ELCC25 #Younginvestigators #LungCancer #EORTC

[Therapeutic Advances in Medical Oncology @TAMedOncol]

New review investigates the role of sex differences in NSCLC patients with driver fusions treated with TKIs. Findings show no significant survival differences by sex, but highlight a knowledge gap in sex-specific responses and toxicity data.

Read more: https://t.co/s1qHIEUgie

[JAMA Oncology @JAMAOnc]

Quitting smoking within 6 months of a cancer diagnosis improves survival outcomes, with the greatest benefits observed in those who enter cessation programs promptly. https://t.co/YhbBrdWVHQ

[Scarlet Berenice Urtecho S @ScarletUrtecho]

Excited to share our latest paper on clinical outcomes of KRAS subtypes in NSCLC! Big thanks to the lung group and my mentor, Dr. @PrelajArsela @IstTumori for making this possible.
Decoding KRAS mutation in non-small cell lung cancer patients: https://t.co/6lHsrxC9SX

[Carolina Reduzzi @ReduzziCarol]

Today we launched the "ISLB Global Survey: Oncologist Attitudes and Practices on Liquid Biopsy" to collect worldwide data on the use of liquid biopsy in clinical practice!
Help us sharing the survey with all the oncologists you know :)
https://t.co/UfwHSj5Pn3

[Mario Occhipinti @MOcchipintiMD]

Excited to share our study on ALK-rearranged NSCLC! We report 3 cases of LCNEC transformation post-ALK-TKI, marking the first reported rate of histologic transformation (4%).
Oncologists, be aware of this resistance mechanism! @IstTumori @ClinicalLung
https://t.co/lxST3HkUFc

[Stephen V Liu, MD @StephenVLiu]

Session on targeted therapy chaired by Drs. @Ritalepp @giusvisc @claudia_proto with @LuisPaz_Ares discussing #EGFR: FLAURA2 vs MARIPOSA - longer PFS but cost of toxicity & infusions. Many prognostic factors, need predictive ones. Ivonescimab - is this the future of IO for EGFR?

[Dr. Luis E. Raez @LuisRaezMD]

Faculty and meentees of
our @IASLC academy that is meeting today at #WCLC24 with @ChristianRolfo @RManochakian @DrSteveMartin @lungoncdoc
@triparnasen @marinagarassino @LudaBazhenovaMD @JPatelMD @ADesaiMD and many others! #lungcancer #lcsm @vidaurremendes

[Rami Manochakian MD, FASCO Cancer Education @RManochakian]

🚨🔥The future of #ThoracicOncology is in GREAT hands!

The final meeting of the 2024 @IASLC #Academy with this OUTSTANDING group of #EarlyCareer #Physicians & #Researchers at #WCLC24.

Honored to serve as academy co-chair with my amazing friend @ChristianRolfo & GREAT faculty.

[Rita Leporati @Ritalepp]

Don’t miss the V edition of the #CocktailWithScience #LungCancer meeting in Milan🫁

👉🏻 https://t.co/WqF5RSlrEY

Hosted by @GLoRussoMD_PhD with a world-class faculty

[EORTC @EORTC]

#MCCRWorkshop The class of 2024 @EORTC - @MyESMO - @AACR Workshop

[Charles Swanton @CharlesSwanton]

Why do some patients benefit less than others from precision cancer medicine? We are excited to share our paper "Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling” out in @NatureComms. https://t.co/e5AYdyrnbx 🧵

[Dr. Luis E. Raez @LuisRaezMD]

Our @IASLC Academy is meeting today again!!, very happy to help young oncologists at the begining of their career! @RManochakian #LCSM @christ #LungCancer @FawziAbuRous @esinghimd @kaushalpar @ADesaiMD @vidaurremendes @RamilaShilpakar @drdaviddwlee @Ritalepp @DrSteveMartin @acmoorephd @triparnasen @JenniferCKing @LudaBazhenovaMD @JessicaJLinMD @marinagarassino @JPatelMD
@Piuchagarrido @AnneTsao2 @ZerAlona
@FedericoCappuz1 @ElinardouHelena
@PranshuMohindra @HwakeleeMD @ChristianRolfo